ArticleCureus2026
Heart-Shaped Subhyaloid Haemorrhage in Valsalva Retinopathy With Successful Delayed Minimally Invasive Management.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Valsalva retinopathy is a recognised cause of acute painless visual loss resulting from a sudden increase in intrathoracic or intra-abdominal pressure, leading to subhyaloid haemorrhage. While most reported cases describe rounded or boat-shaped haemorrhages, atypical morphologies documented with multimodal imaging are infrequently reported. We describe a 45-year-old female with long-standing insulin-treated diabetes mellitus who developed sudden visual blurring following a violent coughing episode. Fundoscopic examination revealed a sharply demarcated, heart-shaped subhyaloid haemorrhage involving the macula, and optical coherence tomography confirmed a subhyaloid haemorrhage. Despite intervention occurring almost three weeks after symptom onset, intravitreal tissue plasminogen activator combined with expansile gas resulted in significant anatomical and functional recovery, with visual acuity improving from 6/36 to 6/9 and sustained improvement on follow-up. This case highlights the importance of recognising atypical haemorrhage morphology, accurately localising haemorrhage depth using optical coherence tomography, and individualising management. It also demonstrates that delayed minimally invasive intervention may achieve excellent visual outcomes, even in the presence of pre-existing retinal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.